Bigjuicy is knocking it out of the park over on se

Bigjuicy is knocking it out of the park over on seekingalpha in my opinion, though I feel we will learn #2 on the mistake list had to be done because it became apparent it was intentional, not simply passive.

Quote:

---

Actually a committee made up of the board of directors are the ones that approve of his raise. He doesn't give himself raises.
If you're wondering why he deserves a raise in the last year he
1. Filed monotherapy protocol with FDA
2. TNBC first patient injection and naive protocol started
3. Phase 2 colorectal cancer protocal approved by FDA
4. Phase 2 NASH
5. Phase 2 GvHD
6. Deal with reputable pharmaceutical manufacturer to defer payments until revenue next year.
7. Raised enough money to keep company afloat through dilution and tender offers.
8. Working on 510k with prostagene(though further off than was led to believe)
Mistakes(in my opinion)
1. Gambled on short term capital raises thinking a license deal was just around the corner. Raising capital at much lower prices and more dilutionary.
2. Fired CMO due to lack of progress, consequently a lawsuit is pending.
3. Delayed HIV filing due to higher success rate of higher dosages of leronlimab.
Note the pros for a raise were all done with a shoestring budget. Cheap animal studies where they could piggyback off the safety data leronlimab had already had in HIV, thereby increasing the true value(not stock value) of the company with smaller expenditures.
So I hear the same broken record that he misses "every" timeline because some people focus on the pessimistic side, some focus on the optimistic side. I'm quite impressed with the accomplishments myself. I'd like a higher stock price, and if a deal falls into place along with capital, the stock will eventually start to meet true value.
If not, and BLA is delayed yet again with more excuses, I may join your pessimism. Until then, I'm still seeing the glass as half full.

---